New Injectable Approved for a Type of Kidney Disease

(MedPage Today) -- The FDA granted accelerated approval to sibeprenlimab injection (Voyxact) for the reduction of proteinuria in adults with primary immunoglobulin A (IgA) nephropathy at risk for disease progression, the agency announced on Tuesday...